Berunda Polypeptides: Biheaded Rapamycin Carriers for Subcutaneous Treatment of Autoimmune Dry Eye Disease-Reference-Cited by-同舟云学术

Berunda Polypeptides: Biheaded Rapamycin Carriers for Subcutaneous Treatment of Autoimmune Dry Eye Disease

Published:2019-05-16 Issue:7 Volume:16 Page:3024-3039
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Lee Changrim¹,Guo Hao¹,Klinngam Wannita¹,Janga Srikanth R.²^ORCID,Yarber Frances²,Peddi Santosh¹,Edman Maria C.²,Tiwari Nishant³,Liu Siyu¹,Louie Stan G.¹,Hamm-Alvarez Sarah F.¹²,MacKay J. Andrew¹²⁴^ORCID

Affiliation:

1. Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, California 90089, United States

2. Department of Ophthalmology, USC Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, California 90089, United States

3. Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, California 90089, United States

4. Department of Biomedical Engineering, Viterbi School of Engineering, University of Southern California, Los Angeles, California 90089, United States

Funder

National Cancer Institute

Research to Prevent Blindness

National Eye Institute

National Institute of Diabetes and Digestive and Kidney Diseases

University of Southern California

L. K. Whittier Foundation

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link